News March 16, 2020
XORTX Launches XRx-101 Following the Filing of a Provisional Patent to Potentially Treat Respiratory and Kidney Disease Injury Due to Coronavirus Infection
https://finance.yahoo.com/news/xortx-launches...46709.html
Currently $0.152 CAD $0.108 USD
52 Week High $0.43 CAD $0.30 USD
See the Corporate profile:
http://www.thestreetnow.com/spotlight/xrx-cse-xrtxf-otcqb/
#medical #coronavirus #BioPharma $LLY $AMGN $SWIS.CN $DECN $MGWFF $BIEI